Dr Reddys Laboratories Operating Expenses Growth & History (RDY)
Dr Reddys Laboratories's operating expenses was $1.39B for fiscal 2025.
View full Dr Reddys Laboratories company overviewDr Reddys Laboratories annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-03-31 | $1.39B | $238.0M | +20.70% |
| 2024 | 2024-03-31 | $1.15B | $150.0M | +15.00% |
| 2023 | 2023-03-31 | $1.00B | −$112.0M | −10.07% |
| 2022 | 2022-03-31 | $1.11B | $35.0M | +3.25% |
| 2021 | 2021-03-31 | $1.08B | $42.0M | +4.06% |
| 2020 | 2020-03-31 | $1.03B | $131.0M | +14.49% |
| 2019 | 2019-03-31 | $904.0M | −$85.0M | −8.59% |
| 2018 | 2018-03-31 | $989.0M | — | — |
Dr Reddys Laboratories operating expenses trends
Over the last five fiscal years, Dr Reddys Laboratories's operating expenses increased from $1.03B to $1.39B, a change of $353.0M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr Reddys Laboratories source filings ↗